Skip to main content

68th Annual Scientific Meeting Main banner

Icon Legend

This session is not in your schedule.

This session is in your schedule. Click again to remove it.

Presentation Icons

Red Recording

Sig Meeting

Jing Wang, n/a

Pfizer R&D, Beijing, China

Poster(s):

(T 32) A phase 3, randomized, double-blind, placebo-controlled, parallel group study to evaluate the efficacy and safety of zavegepant for the acute treatment of migraine in Asian adults
(T 94) Efficacy and safety of zavegepant for the acute treatment of migraine: pooled analysis of two phase 3 randomized controlled trials